Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amarin Co. plc stock logo
AMRN
Amarin
$0.44
$0.53
$0.35
$1.11
$181.52M1.821.38 million shs814,274 shs
biote Corp. stock logo
BTMD
biote
$3.42
-5.8%
$4.48
$3.04
$8.44
$187.11M1.07182,963 shs51,717 shs
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
$1.67
+3.7%
$1.82
$1.26
$3.13
$46.30M0.26131,804 shs31,245 shs
LifeVantage Co. stock logo
LFVN
LifeVantage
$15.84
+0.3%
$18.13
$5.22
$27.38
$198.81M0.74252,146 shs47,766 shs
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amarin Co. plc stock logo
AMRN
Amarin
-1.36%-3.70%-18.44%-8.87%-49.89%
biote Corp. stock logo
BTMD
biote
+9.01%-4.72%-16.93%-41.26%-36.54%
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
-4.17%-12.97%-9.55%-26.82%-44.86%
LifeVantage Co. stock logo
LFVN
LifeVantage
+8.30%+7.71%-8.04%-9.93%+147.10%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amarin Co. plc stock logo
AMRN
Amarin
0.9464 of 5 stars
0.04.00.00.03.30.00.6
biote Corp. stock logo
BTMD
biote
3.4769 of 5 stars
3.53.00.00.03.82.51.3
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
2.8926 of 5 stars
3.53.00.00.03.61.70.6
LifeVantage Co. stock logo
LFVN
LifeVantage
3.2243 of 5 stars
3.51.01.72.70.02.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amarin Co. plc stock logo
AMRN
Amarin
3.00
BuyN/AN/A
biote Corp. stock logo
BTMD
biote
3.00
Buy$8.00133.92% Upside
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
3.00
Buy$7.00319.16% Upside
LifeVantage Co. stock logo
LFVN
LifeVantage
3.00
Buy$30.5092.55% Upside

Current Analyst Ratings Breakdown

Latest IMMX, AMRN, LFVN, and BTMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/13/2025
biote Corp. stock logo
BTMD
biote
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
2/10/2025
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00 ➝ $7.00
1/14/2025
LifeVantage Co. stock logo
LFVN
LifeVantage
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$35.00
1/6/2025
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00 ➝ $7.00
(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amarin Co. plc stock logo
AMRN
Amarin
$228.61M0.79N/AN/A$1.35 per share0.33
biote Corp. stock logo
BTMD
biote
$197.19M0.95$0.36 per share9.60($0.58) per share-5.90
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
N/AN/AN/AN/A$0.81 per shareN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$212.15M0.94$0.83 per share19.03$2.38 per share6.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amarin Co. plc stock logo
AMRN
Amarin
-$59.11M-$0.20N/AN/AN/A-16.33%-7.22%-4.96%5/7/2025 (Estimated)
biote Corp. stock logo
BTMD
biote
$3.32M$0.1813.156.33N/A5.20%-32.41%22.26%5/6/2025 (Estimated)
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
-$15.43M-$0.77N/AN/AN/AN/A-102.68%-80.89%5/8/2025 (Estimated)
LifeVantage Co. stock logo
LFVN
LifeVantage
$2.94M$0.5628.29N/A3.46%34.29%15.04%4/30/2025 (Estimated)

Latest IMMX, AMRN, LFVN, and BTMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025N/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$0.1633N/AN/AN/A$60.99 millionN/A
4/4/2025N/A
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
-$0.25N/AN/AN/AN/AN/A
3/24/2025Q4 2024
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
-$0.25-$0.16+$0.09-$0.16N/AN/A
3/12/2025Q4 2024
Amarin Co. plc stock logo
AMRN
Amarin
-$0.06-$0.12-$0.06-$0.12$32.37 million$62.31 million
2/5/2025Q2 2025
LifeVantage Co. stock logo
LFVN
LifeVantage
$0.14$0.22+$0.08$0.19$67.41 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amarin Co. plc stock logo
AMRN
Amarin
N/AN/AN/AN/AN/A
biote Corp. stock logo
BTMD
biote
N/AN/AN/AN/AN/A
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
N/AN/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$0.161.01%N/A28.57%N/A

Latest IMMX, AMRN, LFVN, and BTMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/3/2025
LifeVantage Co. stock logo
LFVN
LifeVantage
quarterly$0.040.7%3/3/20253/3/20253/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amarin Co. plc stock logo
AMRN
Amarin
N/A
3.23
2.11
biote Corp. stock logo
BTMD
biote
N/A
1.50
1.16
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
N/A
3.47
3.47
LifeVantage Co. stock logo
LFVN
LifeVantage
N/A
1.66
1.03

Institutional Ownership

CompanyInstitutional Ownership
Amarin Co. plc stock logo
AMRN
Amarin
22.25%
biote Corp. stock logo
BTMD
biote
21.68%
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
11.26%
LifeVantage Co. stock logo
LFVN
LifeVantage
35.32%

Insider Ownership

CompanyInsider Ownership
Amarin Co. plc stock logo
AMRN
Amarin
1.96%
biote Corp. stock logo
BTMD
biote
13.90%
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
48.90%
LifeVantage Co. stock logo
LFVN
LifeVantage
20.65%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amarin Co. plc stock logo
AMRN
Amarin
360410.67 million402.62 millionOptionable
biote Corp. stock logo
BTMD
biote
19454.71 million46.78 millionNot Optionable
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
927.72 million14.06 millionOptionable
LifeVantage Co. stock logo
LFVN
LifeVantage
26012.55 million9.96 millionOptionable

Recent News About These Companies

LifeVantage (LFVN) Gets a Buy from Lake Street
Craig-Hallum Sticks to Its Buy Rating for LifeVantage (LFVN)
LifeVantage (LFVN) Gets a Buy from Craig-Hallum
(LFVN) Trading Report
LifeVantage (NASDAQ:LFVN) Is Paying Out A Dividend Of $0.04
Lake Street Keeps Their Buy Rating on LifeVantage (LFVN)
Craig-Hallum Sticks to Their Buy Rating for LifeVantage (LFVN)
Lifevantage trading halted, volatility trading pause

New MarketBeat Followers Over Time

Media Sentiment Over Time

Amarin stock logo

Amarin NASDAQ:AMRN

$0.44 0.00 (0.00%)
As of 03:38 PM Eastern

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

biote stock logo

biote NASDAQ:BTMD

$3.42 -0.21 (-5.79%)
As of 03:33 PM Eastern

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Immix Biopharma stock logo

Immix Biopharma NASDAQ:IMMX

$1.67 +0.06 (+3.73%)
As of 03:03 PM Eastern

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.

LifeVantage stock logo

LifeVantage NASDAQ:LFVN

$15.84 +0.05 (+0.32%)
As of 03:40 PM Eastern

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.